Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.49 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.49 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.49 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5734772 | 0.98 | KMT2A (0.49) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| Hydrochloric Acid SCHEMBL5737488 | 0.98 | KMT2A (0.49) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL342407 | 0.79 | MEN1 (0.59) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL342924 | 0.78 | CA12 (0.50) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL29914372 | 0.75 | CA12 (0.61) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL686591 | 0.75 | CA12 (0.61) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL1403567 | 0.74 | MEN1 (0.82) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL28172287 | 0.74 | KMT2A (0.61) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL1527153 | 0.74 | MEN1 (0.67) | KMT2AMEN1PTPN11RNASEH1GPR35 | |
| SCHEMBL3389929 | 0.73 | KMT2A (0.66) | KMT2AMEN1PTPN11RNASEH1GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116178673-A | Process for preparing composite material by vacuum infusion method | 镇江利德尔复合材料有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-116178673-A | Process for preparing composite material by vacuum infusion method | 镇江利德尔复合材料有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-116178673-A | Process for preparing composite material by vacuum infusion method | 镇江利德尔复合材料有限公司 | 2023-05-30 | — | — | CN | disclosed |
| EP-1244446-B1 | THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORP (US) | 2006-11-02 | — | — | EP | disclosed |
| US-6858630-B2 | Naphthimidazole derivatives and their use as thrombopoietin mimetics | SMITHKLINE BEECHAM CORPORATION (US) | 2005-02-22 | — | — | US | disclosed |
| US-20030083361-A1 | Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia | SMITHKLINE BEECHAM CORPORATION | 2003-05-01 | — | — | US | disclosed |
| EP-1244446-A4 | THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORP (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-1244446-A1 | THROMBOPOIETIN MIMETICS | SmithKline Beecham Corporation (US) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001039773-A1 | THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083361-A1 | Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia | MPL, THPO, TPO | KMT2A 2330/4885MEN1 135/4885PTPN11 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.